Tender Details
Beyond this tender, use our platform to source any product, service, or solution.
Get direct quotes or register as a qualified provider.
About Tender
🚂 Urgent Tender For Monocomponent Biosynthetic R Dna Insulin Solution 💉 The Ministry Of Railways, Under The Central Government, Invites Tenders For The Supply Of Monocomponent Biosynthetic R Dna Insulin Solution, A Blend Of 70% Insulin Degludec And 30% Insulin Aspart, For Injection In A Cartridge, With A Concentration Of 100 Iu/M L, In A Volume Of 3m L. 📅 Submission Deadline: July 15, 2024, 10:30 Am Tender Fees: Inr 0 Emd: Inr 0 Interested Bidders Are Requested To Submit Detailed Tenders, Including All Required Documentation And Compliance With The Specifications Outlined In The Tender Document. Keywords: Insulin Solution, Insulin Degludec, Insulin Aspart, Tender, Ministry Of Railways, Central Government, Pharmaceuticals, Healthcare Supplies| Particulars | Details |
|---|---|
| Title |
(Ph No.:31280) Monocomponent Biosynthetic R Dna Insulin Solution For Injecton In Cartridge 70 Percent Insulin Degludec 30 Percent Insulin Aspart 100 Iu/Ml 3 Ml
|
| Description |
For Complete Deion And Other Details, Please Refer To Tender
|
| Organisation | Ministry of Railways | Central Govt. Ministry/Department |
| Tender Id | 106382073 |
|
Reference Number |
82240629A |
| Tender Fee | 0 |
| EMD | 0 |
| Tender Value | - |
| Place | Secunderabad |
| Link |
View Original Tender Notice
https://www.ireps.gov.in/ireps/supply/pdfdocs/072024/106382073/viewNitPdf_4612287.pdf |
| Start Date | June 20, 2024 15:08 |
| End Date |
Expired
15/07/2024
Expired 823 days ago |
Tender Support
Get help with filing, GeM registration, documents, or relevant tender alerts.
Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml
Hq_med_gte_zrc_zonal rate contract for supply of (ph no.:31280) monocomponent biosynthetic r-dna insulin solution for injecton in cartridge 70 percent insulin degludec + 30 percent insulin aspart - 100 u/ml - 3 ml
Read moreInsulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen
Insulin degludec (2.56mg) insulin aspart (1.05mg) , 3ml prefilled pen
Read moreInsulin degludec (r-dna origin)100iu/ml in 3ml penfills
Insulin degludec (r-dna origin)100iu/ml in 3ml penfills
Read moreInj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.
Inj. biosynthetic r-dna origin mixture of 50 percent soluble insulin aspart (rys) and 50 percent protamine crystallised insulin aspart 100iu/ml 03 ml cartridge with complimentary pen and ultrafine nano needle.
Read moreInj. insulin degludec 100 iu/ml, 3ml cartridge
Inj. insulin degludec 100 iu/ml, 3ml cartridge
Read moreInj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge
Inj.insulin aspart (30 percent ) + insulin aspart protamine (70 percent ) cartridge
Read moreCartr insulin - human regular insulin r dna origin 100iu/ml -3ml
Cartr insulin - human regular insulin r dna origin 100iu/ml -3ml
Read moreBiphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin
Biphasic isophane insulin 30/70 injection (100iu/ml) , (r-dna origin) , 3ml cartridge,multivitamin
Read moreAmino acid, lipids, glucose, electrolytes, triglycerides, nitrogen 5.4g, carbohydrates 100g, energy content total 3780kj, ph 5.6, 1026ml,chromium chloride 4mcg, copper sulphate 0.40mg, manganese sulphate 0.1mg, selenium 20mcg, zinc sulfate 1mg,eicosapentaenoic acid 1.25gm , docosahexanoic acid 1.44gm,tocopherol 0.015 -0.0296 gm,glycerol 2.5 gm,purified egg phosphotide 1.2 gm,sodium celate ,sodium hydroxide ,water for injection 50ml,fish oil 0.1 g, egg phospholipids 0.012 g, glycerin 0.025 g, dl alpha tocopherol 0.15 to 0.3 mg, sodium oleate 0.3 mg, , water for injection, 50 ml,human coagulation factor ii 280-760,human coagulation factor vii 180-480,human ix 500iu,factor x 360-600iu,protein c 260-620iu,protein s 240-640iu , total protein 260-820mg, human prothrombin complex,humi insulin 40iu - monocomponent biosynthetic r-dna insulin 40iu,humi insulin biphasic 40iu soluble insulin , isophane insulin metacresol u.s.p 1.5mg pheno ip - 0.65mg,influenza vaccine adult,insulin glargine 100iu,insulin isophane , human
Amino acid, lipids, glucose, electrolytes, triglycerides, nitrogen 5.4g, carbohydrates 100g, energy content total 3780kj, ph 5.6, 1026ml,chromium chloride 4mcg, copper sulphate 0.40mg, manganese sulphate 0.1mg, selenium 20mcg, zinc sulfate 1mg,eicosapentaenoic acid 1.25gm , docosahexanoic acid 1.44gm,tocopherol 0.015 -0.0296 gm,glycerol 2.5 gm,purified egg phosphotide 1.2 gm,sodium celate ,sodium hydroxide ,water for injection 50ml,fish oil 0.1 g, egg phospholipids 0.012 g, glycerin 0.025 g, dl alpha tocopherol 0.15 to 0.3 mg, sodium oleate 0.3 mg, , water for injection, 50 ml,human coagulation factor ii 280-760,human coagulation factor vii 180-480,human ix 500iu,factor x 360-600iu,protein c 260-620iu,protein s 240-640iu , total protein 260-820mg, human prothrombin complex,humi insulin 40iu - monocomponent biosynthetic r-dna insulin 40iu,humi insulin biphasic 40iu soluble insulin , isophane insulin metacresol u.s.p 1.5mg pheno ip - 0.65mg,influenza vaccine adult,insulin glargine 100iu,insulin isophane , human
Read moreof your Industry type